Chicago hospital treating severe patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.advertisementadvertisementComments are closed.advertisementYou've been selected! Subscribe to STAT+ for less than $2 per daySubscribe to STAT+ for less than $2 per dayUnlimited access to the health care news and insights you need…Chicago hospital treating severe patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.advertisementadvertisementComments are closed.advertisementYou've been selected! Subscribe to STAT+ for less than $2 per daySubscribe to STAT+ for less than $2 per dayUnlimited access to the health care news and insights you needWW…